12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersTenax Therapeutics (NASDAQ:TENX) shares rose 153.2% to $4.28 during Thursday's pre-market session. The company's market cap stands at $9.8 million. Biophytis (NASDAQ:BPTS) stock rose 119.45% to
Top Premarket Decliners
07:47 AM EST, 02/02/2023 (MT Newswires) -- TeraWulf (WULF) shares slumped 33% premarket Thursday, a day after the company launched an underwritten public offering of common stock. OncoSec Medical (ONC
TransCode Therapeutics Offering 12M Shrs >RNAZ
Transcode Therapeutics Files to Sell 12M Shares of Common Stock
Sector Update: Health Care Stocks Edging Lower
01:41 PM EST, 02/01/2023 (MT Newswires) -- Health care stocks were narrowly lower this afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both slipping 0.4%.
Traders Stay Cautious Ahead of Fed Rate Decision, Weighing on US Equity Futures
08:48 AM EST, 02/01/2023 (MT Newswires) -- US equities were set for a cautiously lower open Wednesday as traders looked ahead to the much-awaited monetary policy decision from the US Federal Reserve.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersQuoin Pharmaceuticals (NASDAQ:QNRX) stock rose 76.6% to $2.95 during Wednesday's pre-market session. The company's market cap stands at $14.2 million. TransCode Therapeutics (NASDAQ:RNAZ) stock
Why TransCode Therapeutics (RNAZ) Shares Are Trading Higher Today
TransCode Therapeutics Inc (NASDAQ:RNAZ) reported preclinical proof-of-mechanism studies with its immunotherapy candidate, TTX-RIGA, in melanoma.TTX-RIGA, a novel immunotherapeutic cancer candidate, i
Top Premarket Gainers
07:46 AM EST, 02/01/2023 (MT Newswires) -- Motorsport Games (MSGM) shares increased threefold, extending Tuesday's rally. Quoin Pharmaceuticals (QNRX) shares surged 78% following a 9.7% gain in the pr
TransCode Therapeutics (RNAZ): A Promising Cancer Play
TransCode Therapeutics Inc. (NASDAQ: RNAZ) is a promising biotech company that has been in and out of the market spotlight in recent weeks and months. Its specific area of focus is a specialization on metastatic disease, putting it at the forefront of cancer research. It boasts some key treatment candidates that show significant promise. Positive ...
No Stock Yet